Document is current

Evolocumab als erster PCSK9-Inhibitor zugelassen

Crossref DOI link: https://doi.org/10.1007/s15027-015-0693-x

Published Online: 2015-09-24

Published Print: 2015-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy